[
    {
        "content": "* Appaloosa LP dissolves share stake in Activision Blizzard Inc - SEC filing",
        "date": "11142017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Appaloosa LP cuts share stake in BofA  dissolves share stake in Wells Fargo and Activision Blizzard "
    },
    {
        "content": "U.S. medical device maker Boston Scientific Corp's  shares fell 5 percent on Thursday after disappointing sales in its pacemaker business  even as the company reported better-than-expected revenue overall in the third quarter.",
        "date": "10262017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Boston Scientific dips as pacemaker sales disappoint "
    },
    {
        "content": "Oct 26 U.S. medical device maker Boston Scientific Corp's shares fell 5 percent on Thursday after disappointing sales in its pacemaker business  even as the company reported better-than-expected revenue overall in the third quarter.",
        "date": "10262017",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "UPDATE 2-Boston Scientific dips as pacemaker sales disappoint "
    },
    {
        "content": "* Q3 earnings per share view $0.31 -- Thomson Reuters I/B/E/S",
        "date": "10262017",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific announces results for third quarter 2017 "
    },
    {
        "content": "Oct 26 U.S. medical device maker Boston Scientific Corp's profit rose 24 percent in the third quarter  driven by growth across all its businesses.",
        "date": "10262017",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific's profit rises 24 pct in 3rd quarter "
    },
    {
        "content": "A federal appeals court on Thursday affirmed a trial court's $6.7 million verdict in a 2014 trial for a woman who claimed she was injured by Boston Scientific Corp's transvaginal mesh devices.",
        "date": "10202017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "11th Circuit upholds 2014 Boston Scientific mesh verdict "
    },
    {
        "content": "* Boston Scientific announces agreement to acquire Apama Medical",
        "date": "10022017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific to buy Apama Medical "
    },
    {
        "content": "* Boston scientific appoints Desiree Ralls-Morrison general counsel and corporate secretary Source text for Eikon: Further company coverage:",
        "date": "10042017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific appoints Desiree Ralls-Morrison general counsel and corporate secretary "
    },
    {
        "content": "A federal appeals court on Friday refused to revive a $200 million patent lawsuit filed by a cardiologist against Boston Scientific Corp over coronary stents  saying a lower court judge was right to throw out a jury verdict for the doctor.",
        "date": "09292017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Panel refuses to revive $200 mln stent case against Boston Scientific "
    },
    {
        "content": "* Boston Scientific announces positive late-breaking clinical trial data for the Heartlogic Heart Failure Diagnostic Source text for Eikon: Further company coverage:",
        "date": "09192017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific announces positive late-breaking clinical trial data for Heartlogic Heart Failure Diagnostic "
    },
    {
        "content": "* \u200dVeniti Inc -Boston Scientific will distribute VICI VENOUS STENT under limited global distribution agreement; terms of agreement  specific regions  countries involved were not disclosed\u200b Source text for Eikon:",
        "date": "09112017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Veniti Inc announces Boston Scientific distribution agreement for VICI VENOUS STENT "
    },
    {
        "content": "A federal judge has dismissed a whistleblower lawsuit claiming Boston Scientific Corp caused doctors to make false claims for reimbursement from federal healthcare programs for two defective defibrillator products.",
        "date": "08312017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Judge dismisses Boston Scientific whistleblower complaint "
    },
    {
        "content": "* Boston Scientific Corp - on August 4  2017  Boston Scientific Corporation entered into a $2.25 billion senior unsecured credit facility",
        "date": "08072017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific Corp says entered into a $2.25 bln senior unsecured credit facility- SEC Filing "
    },
    {
        "content": "Boston Scientific Corp  on Thursday reported better-than-expected quarterly profit and revenue as the U.S. medical device maker benefited from strong demand across its businesses  which also helped the company raise full-year expectations.",
        "date": "07272017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Boston Scientific beats profit estimates  raises forecast "
    },
    {
        "content": "July 27 Boston Scientific Corp on Thursday reported better-than-expected quarterly profit and revenue as the U.S. medical device maker benefited from strong demand across its businesses  which also helped the company raise full-year expectations.",
        "date": "07272017",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "UPDATE 2-Boston Scientific beats profit estimates  raises forecast "
    },
    {
        "content": "July 27 Medical device maker Boston Scientific Corp on Thursday posted a profit in the second quarter compared with a year-ago loss  helped by higher sales as well as lower litigation-related expenses.",
        "date": "07272017",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific posts profit in second quarter "
    },
    {
        "content": "* Boston Scientific outlines strategy for sustained growth at 2017 investor day",
        "date": "06272017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific outlines strategy for sustained growth at 2017 investor day "
    },
    {
        "content": "* Boston Scientific receives CE mark for Vercise\u2122 Gevia\u2122 deep brain stimulation system",
        "date": "06062017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific receives CE mark for Vercise Gevia deep brain stimulation system "
    },
    {
        "content": "* Boston Scientific announces positive outcomes from prospective study of bronchial thermoplasty",
        "date": "05242017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific announces positive outcomes from prospective study of bronchial thermoplasty "
    },
    {
        "content": "* The Boston Scientific LOTUS\u2122 valve system demonstrated superior efficacy to Corevalve\u00ae in global reprise III trial at one year",
        "date": "05162017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific announces positive results from the Reprise III clinical trial "
    },
    {
        "content": "* To immediately begin selling Acurate TA and Acurate Neo/TF valve systems in Europe and other geographies outside of U.S. Source text for Eikon: Further company coverage:",
        "date": "05162017",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific closes Symetis acquisition "
    },
    {
        "content": "* Boston scientific announces positive european registry results for watchman\u2122 left atrial appendage closure device",
        "date": "05122017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific says positive European registry results for WATCHMAN left atrial appendage closure device "
    },
    {
        "content": "* Announced results from U.S. post-market approval study evaluating 'real-world' patients implanted with S-ICD System",
        "date": "05112017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific announces results of study evaluating patients implanted with S-ICD System "
    },
    {
        "content": "NEW DELHI Boston Scientific Corp  stands to lose millions of dollars on its high-end heart stent in India after a government panel rejected its request to increase a cap on the price that it can charge for the device.",
        "date": "05092017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "India government panel rejects Boston Scientific plea on stent price caps "
    },
    {
        "content": "* Boston Scientific receives U.S. FDA approval for resonate\u2122 family of high-voltage devices",
        "date": "05092017",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific receives FDA approval for resonate family of high-voltage devices "
    },
    {
        "content": "* Q1 interventional cardiology worldwide sales $605 million versus $560 million",
        "date": "04272017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific reports Q1 GAAP EPS $0.21 "
    },
    {
        "content": "* Boston Scientific initiates global study to assess sudden cardiac arrest prevention therapy in patients with diabetes who have previously experienced a heart attack",
        "date": "04182017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific initiates global study to assess sudden cardiac arrest prevention therapy "
    },
    {
        "content": "Boston Scientific Corp  on Thursday agreed to buy Swiss medical device maker Symetis SA for $435 million  looking to bolster its presence in Europe after recalling a range of heart valves in the region.",
        "date": "03302017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Boston Scientific to expand in Europe with Symetis buy "
    },
    {
        "content": "* Symetis' Acurate devices complementary to Boston Scientific's Lotus valves",
        "date": "03302017",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "UPDATE 3-Boston Scientific to expand in Europe with Symetis buy "
    },
    {
        "content": "* Symetis and Boston Scientific reach USD 435 million purchase agreement",
        "date": "03302017",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "BRIEF-Symetis  Boston Scientific reach $435 mln purchase agreement "
    },
    {
        "content": "* CEO Michael Mahoney's FY 2016 total compensation was $12.0 million versus $11.6 million in FY 2015 - sec filing  Source text (http://bit.ly/2ny4bpM) Further company coverage:",
        "date": "03282017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific CEO Michael Mahoney's FY 2016 total compensation was $12 mln vs $11.6 mln in FY 2015 "
    },
    {
        "content": "* Boston Scientific Corp - deal for $435 million in up-front cash",
        "date": "03302017",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific agrees to acquire Symetis for $435 mln "
    },
    {
        "content": "March 30 Boston Scientific Corp said on Thursday it would buy privately-held Swiss medical device maker Symetis SA for $435 million to expand its business of making minimally invasive heart devices.",
        "date": "03302017",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific to acquire Symetis for $435 mln "
    },
    {
        "content": "NEW YORK  March 13 Investors are seeking shelter in shares of U.S. medical device and supply companies  encouraged by their solid growth prospects and wary that U.S. President Donald Trump's criticism of drug prices makes owning pharmaceutical and biotechnology stocks risky.",
        "date": "03132017",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "U.S. medtech shares gain as investors seek shelter from drug price debate "
    },
    {
        "content": "* District court in Germany ruled that Boston Scientific's lotus valve infringes one of co's patents for transcatheter aortic valves",
        "date": "03092017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-German patent court issues initial decision "
    },
    {
        "content": "* Boston scientific receives favorable rulings in edwards lifesciences litigation",
        "date": "03092017",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific receives favorable rulings in Edwards Lifesciences litigation "
    },
    {
        "content": "* Edwards Lifesciences Corp says company is not changing its financial guidance",
        "date": "03032017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Edwards Lifesciences says UK patent court issues decision on transcatheter heart valves "
    },
    {
        "content": "Boston Scientific Corp said on Thursday it was recalling its Lotus range of heart devices  citing reports of problems with the locking mechanism  sending its shares down as much as 7.4 percent.",
        "date": "02232017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Boston Scientific recalls Lotus Valve heart devices "
    },
    {
        "content": "* Co's last chance to maintain brand equity  interest - Stifel",
        "date": "02232017",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "UPDATE 3-Boston Scientific recalls Lotus Valve heart devices "
    },
    {
        "content": "Feb 23 Boston Scientific Corp said on Thursday it was recalling its range of Lotus Valve heart devices  citing reports of problems with the locking mechanism.",
        "date": "02232017",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific recalls all Lotus Valve heart devices "
    },
    {
        "content": "* Boston Scientific - on February 23 co announced voluntary removal of all Lotus Valve devices - SEC filing",
        "date": "02232017",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific says on Feb. 23 announced voluntary removal of all Lotus Valve devices - SEC filing "
    },
    {
        "content": "The U.S. Supreme Court on Tuesday turned away an appeal by Boston Scientific Corp of a Maryland state court jury verdict ordering the medical device company to pay $308 million to a patent licensor for breach of contract concerning implantable cardiac devices.",
        "date": "02212017",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "U.S. top court rejects Boston Scientific's patent licensing appeal "
    },
    {
        "content": "Feb 21 The U.S. Supreme Court on Tuesday turned away an appeal by Boston Scientific Corp of a Maryland state court jury verdict ordering the medical device company to pay $308 million to a patent licensor for breach of contract concerning implantable cardiac devices.",
        "date": "02212017",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "UPDATE 1-U.S. top court rejects Boston Scientific's patent licensing appeal "
    },
    {
        "content": "Feb 21 The U.S. Supreme Court on Tuesday turned away an appeal by Boston Scientific Corp of a Maryland state court jury verdict ordering the medical device company to pay $308 million to a patent licensor for breach of contract concerning implantable cardiac devices.",
        "date": "02212017",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "U.S. Supreme Court rejects Boston Scientific's patent licensing appeal "
    },
    {
        "content": "* Boston Scientific Corp -  Boston Scientific Corporation entered into a second amended and restated credit and security agreement - SEC filing",
        "date": "02102017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific enters into second amended  restated credit  security agreement "
    },
    {
        "content": "* Boston scientific announces results for fourth quarter and full year ended december 31  2016",
        "date": "02022017",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific sees FY 2017 GAAP earnings per share $0.86 to $0.91 "
    },
    {
        "content": "* Nevro files lawsuit for patent infringement against Boston Scientific in the U.S.",
        "date": "11292016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Nevro files lawsuit for patent infringement against Boston Scientific in the U.S. "
    },
    {
        "content": "* Boston Scientific Corp- specific terms of transaction were not disclosed",
        "date": "11152016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific acquires tissue resection device from Distal Access "
    },
    {
        "content": "* Says unit  Falcon Merger Corp has extended its previously announced tender offer for all shares of EndoChoice Holdings",
        "date": "11042016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific's unit Falcon Merger extends offer for all shares of EndoChoice Holdings "
    },
    {
        "content": "* Boston Scientific announces acquisition of the lumenr\u007f tissue retractor system",
        "date": "11032016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific reports acquisition of the Lumenr tissue retractor system "
    },
    {
        "content": "Boston Scientific Corp's  quarterly revenue beat analysts' estimates  boosted by higher demand for its heart devices  and the medical device maker raised its full-year forecast again.",
        "date": "10262016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Boston Scientific lifts 2016 revenue forecast after beat "
    },
    {
        "content": "Oct 26 Boston Scientific Corp's  quarterly revenue beat analysts' estimates  boosted by higher demand for its heart devices  and the medical device maker raised its full-year forecast again.",
        "date": "10262016",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "RPT-UPDATE 1-Boston Scientific lifts 2016 revenue forecast after beat "
    },
    {
        "content": "* Q4 earnings per share view $0.29  revenue view $2.15 billion -- Thomson Reuters I/B/E/S",
        "date": "10262016",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific Q3 GAAP EPS $0.17 "
    },
    {
        "content": "Oct 26 Boston Scientific Corp reported an 11.5 percent rise in quarterly net sales  boosted by higher demand for its heart devices.",
        "date": "10262016",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Medical device maker Boston Scientific's net sales rise 11.5 pct "
    },
    {
        "content": "Boston Scientific Corp has asked the U.S. Supreme Court to overturn a $308 million Maryland state court jury verdict in a case over a patent licensing deal for implantable defibrillators  arguing that the state court ignored established patent law.",
        "date": "10212016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Boston Scientific asks Supreme Court to toss $308 mln verdict in patent licensing spat "
    },
    {
        "content": "* Professor Ian Meredith to join Boston Scientific as executive vice president and global chief medical officer  Source text for Eikon:  Further company coverage:",
        "date": "10102016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Ian Meredith to join Boston Scientific as executive VP  global chief medical officer "
    },
    {
        "content": "* Boston Scientific commences cash tender offer for all shares of EndoChoice for $8.00 per share in cash",
        "date": "10072016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific commences cash tender offer for all shares of EndoChoice for $8.00 per share in cash "
    },
    {
        "content": "* Agreement with Boston Scientific provides termination fee of $7.95 million under certain circumstances  Source text for Eikon:  Further company coverage:",
        "date": "09272016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-EndoChoice holdings agreement with Boston Scientific provides termination fee of $7.95 million under certain circumstances "
    },
    {
        "content": "* To evaluate strategic options with respect to FUSE colonoscope  and expects to provide further clarity at/around time of deal closing",
        "date": "09272016",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific to acquire EndoChoice for $8.00/share "
    },
    {
        "content": "* Ups share stake in Valeant Pharmaceuticals International Inc by 43.6 pct to 19.1 mln shares - SEC filing",
        "date": "08152016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Paulson & Co raises share stake in Valeant  Facebook - SEC filing "
    },
    {
        "content": "* FDA approval for magnetic resonance (MR) conditional labeling for all previously implanted Emblem S-ICD systems  Source text for Eikon:  Further company coverage:",
        "date": "08092016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific gets FDA approval for Emblem MRI system "
    },
    {
        "content": "* Sees Cosman Medical team and products will become part of Boston Scientific neuromodulation business",
        "date": "07272016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific announces acquisition of Cosman Medical "
    },
    {
        "content": "Boston Scientific Corp reported better-than-expected quarterly sales as it sold more of its heart devices and revenue from its troubled cardiac rhythm management business increased.",
        "date": "07282016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Boston Scientific's sales beat on demand for heart devices "
    },
    {
        "content": "July 28 Boston Scientific Corp reported better-than-expected quarterly sales as it sold more of its heart devices and revenue from its troubled cardiac rhythm management business increased.",
        "date": "07282016",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "UPDATE 1-Boston Scientific's sales beat on demand for heart devices "
    },
    {
        "content": "July 28 Medical device maker Boston Scientific Corp reported a 15.4 percent rise in quarterly sales as it sold more of its cardiac devices.",
        "date": "07282016",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific reports higher sales on demand for heart devices "
    },
    {
        "content": "* Boston Scientific elects Yoshiaki Fujimori to board of directors  Source text for Eikon:  Further company coverage:",
        "date": "07132016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific elects Yoshiaki Fujimori to board "
    },
    {
        "content": "* Board increased the number of directors comprising the board from ten to eleven - sec filing  Source text for Eikon:  Further company coverage:    (Bengaluru Newsroom: +1-646-223-8780)",
        "date": "07132016",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific says board increased number of directors from ten to eleven "
    },
    {
        "content": "NAIROBI The lawyer representing Kenya's suspended Rita Jeptoo  the Boston and Chicago marathon winner  has withdrawn her services a day before the start of a hearing into the athlete's doping case at the Court of Arbitration for Sport (CAS).",
        "date": "07062016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Jeptoo's lawyer withdraws from CAS hearing "
    },
    {
        "content": "NAIROBI  July 6 The lawyer representing Kenya's suspended Rita Jeptoo  the Boston and Chicago marathon winner  has withdrawn her services a day before the start of a hearing into the athlete's doping case at the Court of Arbitration for Sport (CAS).",
        "date": "07062016",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Doping-Jeptoo's lawyer withdraws from CAS hearing "
    },
    {
        "content": "* Reaffirms FY 2016 revenue guidance provided on April 27  for estimated revenue to be in a range of $8.075 to $8.225 billion",
        "date": "06092016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific reaffirms 2016 revenue guidance "
    },
    {
        "content": "June 8 Medical device maker Boston Scientific Corp said on Wednesday it would undergo a global restructuring program that is expected to save the company up to $150 million by 2020.",
        "date": "06092016",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific to restructure in bid to reduce operating expenses "
    },
    {
        "content": "Medical device maker Edwards Lifesciences Corp has filed claims that rival Boston Scientific Corp's new heart valve replacement system  which is not yet for sale in the U.S.  infringes several of Edwards' patents.",
        "date": "06132016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Edwards hits back at Boston Scientific in heart valve patent case "
    },
    {
        "content": "* Boston scientific announces positive long-term outcomes for S-ICD system in the EFFORTLESS study",
        "date": "05062016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific announces positive long-term outcomes for S-ICD system "
    },
    {
        "content": "* Announces U.S. FDA approval of navigation-enabled ablation catheters  Source text for Eikon:  Further company coverage:    (Bengaluru Newsroom: +1-646-223-8780)",
        "date": "05032016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific announces FDA approval of navigation-enabled ablation catheters "
    },
    {
        "content": "Boston Scientific Corp reported a higher-than-expected quarterly profit and raised its full-year revenue forecast  helped by strong sales of new devices for heart patients.",
        "date": "04272016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Boston Scientific hits 10-year high on strong results  forecast "
    },
    {
        "content": "* Shares surge 12 pct to 10-year high   (Adds second quarter forecast  updates shares)",
        "date": "04272016",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "UPDATE 5-Boston Scientific hits 10-year high on strong results  forecast "
    },
    {
        "content": "* Q1 earnings per share view $0.24 -- Thomson Reuters I/B/E/S",
        "date": "04272016",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific Q1 adjusted EPS $0.28 excluding items "
    },
    {
        "content": "* Receives U.S. FDA approval for Imageready(Tm) MR-conditional pacing system",
        "date": "04252016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific receives U.S. FDA approval for ImageReady MR-conditional pacing system "
    },
    {
        "content": "Boston Scientific Corp has sued a rival medical device company alleging that its replacement heart valve and several related products infringe Boston Scientific patents.",
        "date": "04212016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Boston Scientific sues Edwards over heart valve replacement patents "
    },
    {
        "content": "April 4 Boston Scientific Corp on Monday said it has temporarily stopped selling a newer version of its Watchman atrial fibrillation treatment in Europe due to a higher-than-expected rate of embolisms associated with the implant.",
        "date": "04042016",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific says suspends Watchman FLX sales in Europe "
    },
    {
        "content": "* CEO Michael Mahoney's 2015 total compensation was $11.6 million versus $10.5 million in 2014 - SEC Filing  Source text: http://1.usa.gov/1q0NaTp Further company coverage:",
        "date": "03222016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "BRIEF-Boston Scientific CEO's 2015 compensation was $11.6 mln "
    },
    {
        "content": "Heart device maker Boston Scientific Corp's  quarterly revenue fell just shy of Wall Street expectations as sales in its second-biggest unit fell  sending its shares down as much as 6 percent.",
        "date": "02042016",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Heart device maker Boston Scientific's sales miss estimates "
    },
    {
        "content": "* Shares fall as much as 6 pct   (Adds conference call details  analyst comment  background  shares)",
        "date": "02042016",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "UPDATE 2-Heart device maker Boston Scientific's sales miss estimates "
    },
    {
        "content": "A Missouri jury has cleared medical device manufacturers Boston Scientific and C.R. Bard of liability in the first trial involving a woman who said she was injured by transvaginal mesh devices made by more than one company.",
        "date": "02042016",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific  C.R. Bard win defense verdicts in mesh trial "
    },
    {
        "content": "Feb 4 Medical device maker Boston Scientific Corp reported a 4.8 percent rise in quarterly revenue  boosted by higher sales in its surgical equipment unit.",
        "date": "02042016",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific reports 4.8 pct rise in quarterly revenue "
    },
    {
        "content": "A federal judge in California has sent back to state court 62 cases from women in 21 states who claim they were injured by Boston Scientific Corp's transvaginal mesh devices  saying the company had waited too long to remove the lawsuits to federal court.",
        "date": "10272015",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Boston Scientific loses bid to keep 62 mesh suits out of state court "
    },
    {
        "content": "Medical device maker Boston Scientific Corp  reported a better-than-expected quarterly profit and raised its full-year profit forecast  as its expects a pick up in sales due to new devices.",
        "date": "10282015",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Boston Scientific profit beats Street on demand for surgical products "
    },
    {
        "content": "* Shares up 4 pct in light premarket trading   (Adds forecast)",
        "date": "10282015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "UPDATE 2-Boston Scientific profit beats Street on demand for surgical products "
    },
    {
        "content": "Oct 28 Medical device maker Boston Scientific Corp reported a 2.3 percent rise in quarterly revenue as sales rose in all three of its divisions.",
        "date": "10282015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific's revenue rises about 2 pct "
    },
    {
        "content": "NEW YORK  Oct 9 A Delaware judge on Friday said Boston Scientific should only have to pay $10 million to a woman originally awarded $100 million by a jury who found she was injured by transvaginal mesh  a device that is the subject of thousands of lawsuits.",
        "date": "10092015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific mesh verdict slashed to $10 million "
    },
    {
        "content": "NEW YORK  Aug 18 In July 2013  California urogynecologist Andrew Cassidenti received an email from an entrepreneur named Otto Fisher  who had a proposition. Fisher was looking for surgeons to perform operations to remove pelvic mesh implants from women.",
        "date": "08182015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "SPECIAL REPORT-Investors profit by funding surgery for desperate women patients "
    },
    {
        "content": "Aug 19 Medical device maker Boston Scientific Inc said its stent to prevent the blocking of arteries in the legs was approved in the United States  four years after the device was recalled outside the country due to partial or no deployments.",
        "date": "08192015",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "UPDATE 1-Boston Scientific's stent approved for peripheral artery disease "
    },
    {
        "content": "Boston Scientific Corp  cut its full-year profit forecast for the second time in the face of rising litigation costs linked to problems with its implantable device used to treat feminine stress urinary incontinence.",
        "date": "07232015",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Boston Scientific cuts profit forecast again as legal costs mount "
    },
    {
        "content": "July 23 Boston Scientific Corp cut its full-year profit forecast for the second time in the face of rising litigation costs linked to problems with its implantable device used to treat feminine stress urinary incontinence.",
        "date": "07232015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "UPDATE 1-Boston Scientific cuts profit forecast again as legal costs mount "
    },
    {
        "content": "July 23 Medical device maker Boston Scientific Corp  dogged by  litigation expenses last year  reported a jump in quarterly profit.",
        "date": "07232015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific profit soars "
    },
    {
        "content": "A Delaware jury on Thursday ordered Boston Scientific to pay $100 million to a woman who said she was injured by transvaginal mesh  a device that is the subject of more than 25 000 lawsuits against the company.",
        "date": "05282015",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Boston Scientific ordered to pay $100 mln in transvaginal mesh trial "
    },
    {
        "content": "A Delaware jury on Thursday ordered Boston Scientific to pay $100 million to a woman who said she was injured by transvaginal mesh  a device that is the subject of more than 25 000 lawsuits against the company.",
        "date": "05282015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific ordered to pay $100 million in transvaginal mesh trial "
    },
    {
        "content": "May 28 A Delaware jury on Thursday ordered Boston Scientific to pay $100 million to a woman who said she was injured by transvaginal mesh  a device that is the subject of more than 25 000 lawsuits against the company.",
        "date": "05282015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "UPDATE 3-Boston Scientific ordered to pay $100 mln in transvaginal mesh trial "
    },
    {
        "content": "May 28 A Delaware jury on Thursday ordered Boston Scientific to pay $100 million to a woman who said she was injured by transvaginal mesh  a device that is the subject of more than 25 000 lawsuits against the company.",
        "date": "05282015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "U.S. jury orders Boston Scientific to pay $100 mln in transvaginal mesh trial "
    },
    {
        "content": "Boston Scientific agreed to settle a lawsuit from a woman who said she was injured by one of the company's transvaginal mesh devices  which have been the target of more than 26 000 cases.",
        "date": "05112015",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Boston Scientific settles bellwether mesh case in California "
    },
    {
        "content": "Boston Scientific Corp expects more hospitals will be able to offer its new atrial fibrillation treatment starting by the end of the third quarter as it paces the product's rollout to give physicians time to learn how to use it  its chief executive said.",
        "date": "04282015",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Boston Scientific says atrial fibrillation device in demand "
    },
    {
        "content": "Boston Scientific Corp on Tuesday said it reached its first settlement agreement to resolve a portion of the legal claims it faces involving its transvaginal mesh product to treat urinary incontinence.",
        "date": "04282015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific reaches first transvaginal mesh settlement "
    },
    {
        "content": "April 28 Boston Scientific Corp on Tuesday said it reached its first settlement agreement to resolve a portion of the legal claims it faces involving its transvaginal mesh product to treat urinary incontinence.",
        "date": "04282015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "UPDATE 1-Boston Scientific reaches first transvaginal mesh settlement "
    },
    {
        "content": "April 28 Boston Scientific Corp on Tuesday said it has reached an agreement to settle a portion of the legal claims it faces involving its transvaginal mesh product to treat urinary incontinence.",
        "date": "04282015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific says to settle some transvaginal mesh cases "
    },
    {
        "content": "NEW YORK  April 24 Healthcare companies on a seven-year tear have been top performers so far in 2015  helping to push broad stock indexes to record levels  but traders are now looking to protect themselves from a selloff as they await major earnings reports in the sector.",
        "date": "04242015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Wall St Week Ahead-Investors seek protection against healthcare stock decline "
    },
    {
        "content": "April 28 Boston scientific says it reached conditional agreement to settle some transvaginal mesh cases Boston scientific says it will pay about $119 million to resolve 2 970 cases Boston scientific says it increased its product liability reserves for transvaginal mesh litigation Boston scientific says reserves cover known and estimated future cases   (Reporting by Susan Kelly in Chicago)",
        "date": "04282015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific says reaches conditional settlement in some transvaginal mesh cases "
    },
    {
        "content": "April 28 Medical device maker Boston Scientific Corp cut its full-year revenue and profit forecasts as it continues to bear the brunt of charges from a number of lawsuits.",
        "date": "04282015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "UPDATE 1-Boston Scientific cuts full-year forecast as legal costs weigh "
    },
    {
        "content": "April 28 Medical device maker Boston Scientific Corp reported a quarterly net loss due to one-time charges  including litigation costs of $193 million.",
        "date": "04282015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific posts loss on litigation costs "
    },
    {
        "content": "March 13 Boston Scientific Corp said on Friday that the U.S. Food and Drug Administration approved its device to prevent stroke in patients with a dangerous irregular heart rhythm known as atrial fibrillation (AF).",
        "date": "03132015",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "UPDATE 2-Boston Scientific gets U.S. OK for Watchman heart device "
    },
    {
        "content": "Boston Scientific Corp said on Friday that the U.S. Food and Drug Administration approved its device to prevent stroke in patients with a dangerous irregular heart rhythm known as atrial fibrillation (AF).",
        "date": "03132015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific gets U.S. OK for Watchman heart device "
    },
    {
        "content": "March 13 Boston Scientific Corp said the U.S. Food and Drug Administration on Friday approved its device to prevent stroke in patients with a dangerous irregular heart rhythm known as atrial fibrillation.",
        "date": "03132015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific wins U.S. approval for atrial fibrillation device "
    },
    {
        "content": "BRUSSELS  March 5 U.S. medical device maker Boston Scientific Corp's German arm is liable for the cost of operations to replace potentially defective pacemakers  Europe's top court ruled on Thursday.",
        "date": "03052015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "EU court rules Boston Scientific must pay pacemaker replacement surgery "
    },
    {
        "content": "Medical device maker Boston Scientific Corp  said it will buy Endo International Plc's  American Medical Systems' men's and prostate health business for up to $1.65 billion.",
        "date": "03022015",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Boston Scientific to buy Endo's urology portfolio for $1.65 billion "
    },
    {
        "content": "March 2 Medical device maker Boston Scientific Corp said it will buy Endo International Plc's  American Medical Systems' men's and prostate health business for up to $1.65 billion.",
        "date": "03022015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "UPDATE 1-Boston Scientific to buy Endo's urology portfolio for $1.65 bln "
    },
    {
        "content": "March 2 Boston Scientific Corp said it will acquire Endo International Plc's American Medical Systems urology portfolio for up to $1.65 billion.",
        "date": "03022015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific to buy Endo's urology portfolio for up to $1.65 bln "
    },
    {
        "content": "Feb 24 The following bids  mergers  acquisitions and disposals were reported by 2100 GMT on Tuesday:",
        "date": "02242015",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Deals of the day- Mergers and acquisitions "
    },
    {
        "content": "NEW YORK Boston Scientific Corp  is close to buying Endo International PLC's  AMS medical device unit  a deal that could value the business at around $2 billion  according to people familiar with the matter.",
        "date": "02242015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific near deal to buy Endo's device unit: sources "
    },
    {
        "content": "Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson & Johnson to settle a long-running lawsuit over Boston Scientific's 2005 acquisition of rival Guidant.",
        "date": "02172015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific to pay J&J $600 million to settle Guidant suit "
    },
    {
        "content": "Feb 17 Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson & Johnson to settle a long-running lawsuit over Boston Scientific's 2005 acquisition of rival Guidant.",
        "date": "02172015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "UPDATE 1-Boston Scientific to pay J&J $600 mln to settle Guidant suit "
    },
    {
        "content": "(The following statement was released by the rating agency) CHICAGO  February 17 (Fitch) Boston Scientific Corp.'s (NYSE: BSX) ratings are  unaffected by its recent settlement with Johnson & Johnson (NYSE: JNJ) regarding  litigation associated with BSX's acquisition of Guidant in 2006  according to  Fitch Ratings.  The settlement calls for BSX to pay $600 million to JNJ during 2015. BSX will  make two $300 million dollar payments  primarily using balance sheet cash  without taking on any additio",
        "date": "02172015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Fitch: Boston Scientific's Settlement Reduces Liability Risk but Also Liquidity "
    },
    {
        "content": "Feb 17 Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson & Johnson to settle a long-running breach of merger lawsuit over Boston Scientific's 2005 acquisition of rival Guidant.",
        "date": "02172015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific to pay J&J $600 mln to settle Guidant suit "
    },
    {
        "content": "Boston Scientific Corp's adjusted quarterly profit edged past the average analyst estimate and the medical device maker reported a growth in sales for the fifth straight quarter  helped by continued demand for its heart devices.",
        "date": "02042015",
        "name": "Boston Scientific Corporation",
        "news_type": "topStory",
        "symbol": "BSX",
        "title": "Boston Scientific profit beats Street by a cent "
    },
    {
        "content": "* Shares touch seven-year high   (Adds detail  analyst comment; updates share)",
        "date": "02042015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "UPDATE 2-Boston Scientific profit beats Street by a cent "
    },
    {
        "content": "Feb 4 Medical device maker Boston Scientific Corp posted a 19 percent fall in fourth-quarter profit as litigation charges more than doubled.",
        "date": "02042015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Boston Scientific profit falls as litigation costs soar "
    },
    {
        "content": "NEW YORK  Jan 21 For more than eight years  Johnson & Johnson has pursued billions of dollars in damages against Boston Scientific Corp after the latter won a controversial - and ultimately ill-fated - bidding war for device maker Guidant.",
        "date": "01222015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "J&J's $7.2 bln claim against Boston Scientific now with U.S. judge "
    },
    {
        "content": "NEW YORK For more than eight years  Johnson & Johnson  has pursued billions of dollars in damages against Boston Scientific Corp  after the latter won a controversial \u2013 and ultimately ill-fated \u2013 bidding war for device maker Guidant.",
        "date": "01222015",
        "name": "Boston Scientific Corporation",
        "news_type": "normal",
        "symbol": "BSX",
        "title": "Johnson & Johnson's $7.2 billion claim against Boston Scientific now with U.S. judge "
    }
]